关注
Lyron Co Ting Keh
Lyron Co Ting Keh
在 stanford.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Integrating genomic features for non-invasive early lung cancer detection
JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ...
Nature 580 (7802), 245-251, 2020
5192020
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ...
Nature biotechnology 39 (12), 1537-1547, 2021
2102021
Phased variant enrichment for enhanced minimal residual disease detection from cell-free DNA
DM Kurtz, J Soo, S Alig, LCT Keh, C Macaulay, MC Jin, F Scherer, ...
Blood 134, 552, 2019
72019
Phased variants improve DLBCL minimal residual disease detection at the end of therapy.
DM Kurtz, JJ Chabon, J Soo, L Co Ting Keh, S Alig, A Schultz, MC Jin, ...
Journal of Clinical Oncology 39 (15_suppl), 7565-7565, 2021
42021
Leveraging phased variants for personalized minimal residual disease detection in localized non-small cell lung cancer.
DM Kurtz, JJ Chabon, B Sworder, L Co Ting Keh, J Soo, S Alig, A Schultz, ...
Journal of Clinical Oncology 39 (15_suppl), 8518-8518, 2021
32021
系统目前无法执行此操作,请稍后再试。
文章 1–5